Introduction: Diabetes is a disease characterized by an increase in blood glucose due to disorders in insulin production, this disease is widely distributed throughout the world. Objective: to review and systematize the general information on diabetes, as well as the traditional treatments and the findings on kombucha as an alternative method. Method: the information retrieval technique or literature review was used on the topics of diabetes, allopathic methods, kombucha, preparation procedures, chemical and microbiological components and pharmacological effects of the drink. Results: Various sources of information were found that explain the definition of diabetes and its classification. it commonly presents in four ways depending on the signs, the common ones being type 1, associated with destruction of the β cells of the pancreas and mainly affects minors, and type 2, which is related to genetic and environmental problems and It affects people over 18 years of age, and less frequently gestational diabetes and MODY type. Traditional drugs such as sulfonylureas, glinides and biguanides, thiazolidinediones and α-glucosidase inhibitors are used to control this disease, or alternative therapies are used such as kombucha, a fermented beverage that has its origins in China and is spread worldwide by its beneficial effects in chronic degenerative diseases such as diabetes, due to its chemical and microbiological content. Conclusion: The information establishes important data on kombucha as one of the complementary alternatives for the treatment of diabetes.
References
[1]
Aguilar, S.C.A., Hernández, J.S., Hernández, A.M. and Hernández, A.J.E. (2015) Actions to Face Diabetes. National Academy of Medicine CONACYT, Intersystem Publishers, Mexico.
[2]
Kaufman, F.R. (2012) Medical Management of Type 1 Diabetes. 6th Edition, American Diabetes Association, Alexandria, VA.
[3]
Alberti, K.G. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a Who Consultation. Diabetic Medicine, 15, 539-553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
[4]
World Health Organization (2016) World Diabetes Report. https://apps.who.int/iris/bitstream/handle/10665/254649/9789243565255-spa.pdf;jsessionid=E03E6CAD2FC6B046DC34747F6287A0C9?sequence=1
[5]
Amaya-Chávez, A., Dolores-Ledezma, E., álvarez-Sánchez, P., Ferreira-Rubio, G., Gómez-Oliván, L.M. and Galar-Martínez, M. (2007) Evaluation of a Type 2 Diabetes Model to Study the Hypoglycemic Activity of Glibenclamide. Mexican Journal of Pharmaceutical Sciences, 38, 5-11.
[6]
De Vicente A.I.I., Osejo, B.M., Rodríguez, L.A., Rodas, G.S.B., Ramos, G.M.A. and ávila, T.D.M. (2019) Metformin: Clinical Use and Update. Journal of Honduran Medicine, 87, 28-32. https://doi.org/10.5377/rmh.v87i1.11935
[7]
Illana, C. (2007) The Kombucha Mushroom. Bulletin Mycology Society of Madrid, 31, 269-272.
[8]
González-Téllez, S.V., Vázquez-Olivares, D.A., Espinosa-Raya, J.B. and Gómez Pliego, R.A. (2019) Comparative Study of the Microbiota Isolated from the Kombucha Mushroom and Its Use in the Production of Fermented Foods for Metabolic Syndrome. Research and Development in Food Science and Technology, 4, 237-247.
[9]
Velasco-Guzmán, B.J. and Brena-Ramos, V.M. (2014) Diabetes Mellitus Type 2: Epidemiology and Health Emergency. Health and Administration Magazine, 1, 11-16.
[10]
Alvarez-Cordero, R. (2017) From the Discovery of Insulin to Metabolic Surgery for Diabetes. Acta Médica Grupo Angeles, 15, 148-149. https://doi.org/10.35366/72352
[11]
Olinda, D.F. and Shenoy, C.K. (2016) Protective Effect of Kombucha on Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats. International Journal of Science and Research, 5, 945-948. https://doi.org/10.21275/v5i3.NOV161951
[12]
Pérez-Díaz, I. (2016) Mellitus Diabetes. Medical Gazette of Mexico, 152, 50-55.
Irigoyen, C.A.E., Ayala, A.C., de la Roche, O.F.R. and Calzada, H.E. (2017) Diabetes Mellitus and Its Social and Clinical Implications in Mexico and Latin America. Archives in Family Medicine, 19, 91-94.
[15]
Rivas, A.E.M., Zerquera, T.G., Hernández, G.C. and Vicente, S.B. (2011) Practical Management of Patients with Diabetes Mellitus in Primary Health Care. Finlay Magazine, 7, 229-250.
[16]
Garcia, G.E. (2017) Update on Type 1 Diabetes. In: Paediatrics Update Course 2017, Lúa Ediciones 3.0, Actualizaciones en Pediatría ,Madrid, 397-403.
[17]
Barquilla, G.A. (2017) Brief Update on Diabetes for General Practitioners. Revista Española de Sanidad Penitenciaria, 19, 57-65.
[18]
Medina-Pérez, E.A., Sánchez-Reyes, A., Hernández-Peredo, A.R., Martínez-López, M.A., Jiménez-Flores, C.N., Serrano-Ortiz, I. and Cruz-González, M. (2017) Gestational Diabetes. Diagnosis and Treatment at the First Level of Care. Internal Medicine of Mexico, 33, 91-98.
[19]
Cervantes-Villagrana, R.D. and Presno-Bernal, J.M. (2013) Pathophysiology of Diabetes and Mechanisms of Pancreatic β-Cell Death. Revista de Endocrinología y Nutrición, 21, 98-106.
Palmezano-Díaz, J.M., Figueroa-Pineda, C.L., Rodríguez, R., Plazas-Rey, L., Corredor-Guzmán, K., Pradilla-Suárez, L.P. and Coha-Díaz, J.P. (2018) Clinical and Sociodemographic Characteristics of Patients with Type 1 Diabetes in a University Hospital in Colombia. Internal Medicine of Mexico, 34, 46-56.
[22]
Ferraro, M., Ramos, O. and Strasnoy, I. (2013) Type 1 Diabetes Mellitus. Practical Pediatrics, 4, 1-60.
[23]
Rubio, C.O. and Argente, J. (2012) Diabetes Mellitus: Forms of Clinical Presentation and Differential Diagnosis of Hyperglycemia in Childhood and Adolescence. Annals of Pediatrics (Barc), 77, 344.e1-344.e16. https://doi.org/10.1016/j.anpedi.2012.06.013
[24]
Flores, R.J. and Aguilar, R.F. (2006) Diabetes Mellitus and Its Complications. The Epidemiology, Clinical Manifestations of Type 1 and 2 Diabetes. Gestational Diabetes I. Neurological Plasticity & Restoration, 5, 139-151.
Hayes, D.J.P. (2008) Type 1 Diabetes Mellitus. Journal of the Bolivian Society of Pediatrics, 47, 90-96.
[27]
Working Group of the Clinical Practice Guideline on Type 1 Diabetes Mellitus. (2012) Clinical Practice Guideline on Type 1 Diabetes Mellitus. Quality Plan for the National Health System of the Ministry of Health and Social Policy. Basque Country Health Technology Assessment Agency. Clinical Practice Guidelines in the SNS: OSTEBA No. 2009/10.
[28]
Working Group of the Clinical Practice Guideline on Type 2 Diabetes Mellitus. (2008) Clinical Practice Guide on Type 2 Diabetes. Clinical Practice Guide on Type 2 Diabetes. Madrid: National Plan for the National Health System of the Ministry of Health and Social Policy. Basque Country Health Technology Assessment Agency. Clinical Practice Guideline in the SNS: OSTEBA No. 2006/08.
[29]
Perez, B.F. (2009) Epidemiology and Pathophysiology of Type 2 Diabetes Mellitus. Revista Médica Clínica Las Condes, 20, 565-571.
[30]
Mediavilla, J. (2002) Therapy. Current Treatment of Type 2 Diabetes Mellitus. Integrative Medicine, 39, 25-35.
[31]
Sánchez-Turcios, R.A. and Hernández-López, E. (2011) Gestational Diabetes Mellitus. Current Perspectives. Medical Journal of the Mexican Social Security Institute, 49, 503-510.
[32]
Frías-Ordoñez, J.S., Pérez-Gualdrón, C.E. and Saavedra-Ortega, D.R. (2016) Gestational Diabetes Mellitus: An Approach to Current Concepts on Diagnostic Strategies. Journal of the Faculty of Medicine, 64, 769-775. https://doi.org/10.15446/revfacmed.v64n4.54569
[33]
Perera, O.P., de la Vega, P.A. and González, C.O. (2006) Pathophysiology and Nutritional Care of Patients with Gestational Diabetes. Gynecology and Obstetrics of Mexico, 74, 218-223.
[34]
Espinoza, A.A. and Fernandez, V.R. (2019) The New in Diagnosis and Treatment of Gestational Diabetes Mellitus. Synergy Medical Journal, 4, 41-54. https://doi.org/10.31434/rms.v4i4.180
[35]
Parodi, K. and Jose, S. (2016) Diabetes and Pregnancy. Journal Faculty of Medical Sciences, 13, 27-35.
[36]
Conget, I. (2002) Diagnosis, Classification and Pathogenesis of Diabetes Mellitus. Spanish Journal of Cardiology, 55, 528-535. https://doi.org/10.1016/S0300-8932(02)76646-3
[37]
Aloulou, A., Hamden, K., Elloumi, D., Ali, M.B., Hargafi, K., Jaouadi, B. and Ammar, E. (2012) Hypoglycemic and Antilipidemic Properties of Kombucha Tea in Alloxan-Induced Diabetic Rats. BMC Complementary and Alternative Medicine, 12, Article 63. https://doi.org/10.1186/1472-6882-12-63
[38]
Mellado-Orellana, R., Salinas-Lezama, E., Sánchez-Herrera, D., Guajardo-Lozano, J., Juan, E. and Rodríguez-Weber, F.L. (2019) Pharmacological Treatment of Type 2 Diabetes Mellitus Aimed at Overweight and Obese Patients. Internal Medicine of Mexico, 35, 525-536.
[39]
Pallardo, S.L.P. (2008) Sulfonylureas in the Treatment of Patients with Type 2 Diabetes Mellitus. Endocrinology and Nutrition, 55, 17-25.
[40]
Rodríguez-Rivera, N.S., Cuautle-Rodríguez, P. and Molina-Guarneros, J.A. (2017) Oral Hypoglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Use and Regulation in Mexico. Journal of the Juarez Hospital of Mexico, 84, 203-211.
[41]
Arroyo, D. and Goicoechea, M. (2020) Up-to-Date Nephrology. Oral Antidiabetic Drugs and Insulins. https://www.nephrologiaaldia.org/330
[42]
Benavides, M.M.J., Bruscas, A.M.J., Mozota, D.J. and Medrano, S.S. (2000) New Oral Antidiabetics for the Treatment of Type 2 Diabetes Mellitus. Medicina Integral, 36, 355-358.
[43]
Del Olmo, G.E., Carrillo, P.M. and Aguilera, G.S. (2008) Update on Pharmacological Treatment of Type 2 Diabetes Mellitus. Informe Ter Sistema Nacionalde Salud, 32, 1-16.
[44]
Morantes-Caballero, J.A., Londoño-Zapata, G.A., Rubio-Rivera, M. and Pinilla-Roa, A.E. (2017) Metformin: Beyond Glycemic Control. UIS Medical, 30, 57-71. https://doi.org/10.18273/revmed.v30n1-2017005
[45]
González-Sánchez, A. and Ortiz-Andrade, R. (2012) What Do You Know about... Oral Antidiabetics (OAD’s)? Mexican Journal of Pharmaceutical Sciences, 43, 79-84.
[46]
Herrera, H.J.M. (2008) Use of Thiazolidinediones in Type 2 Diabetic Patients. Revista Médica de Costa Rica y Centroamérica, 65, 53-58.
[47]
Hernández, Y.A., Torres, H.O., Carrasco, M.B., Nasiff, H.A., Elías-Calles, L.C., Pérez, P.L. and Fernández, V.F. (2011) Pharmacological Treatment of Prediabetes. Cuban Journal of Endocrinology, 22, 36-45.
[48]
Hernández-Jiménez, S., Aguilar-Salinas, C.A. and Gómez-Pérez, F.J. (2002) Thiazolidinediones. Real Benefits and Risks. Journal of Endocrinology and Nutrition, 10, 69-76.
[49]
Silva, R.J.D., Silva, R.N.G. and Vargas, A.J.S. (2019) Inhibition of α-Glucosidase by Naturally Occurring Flavonoids as a Control Pathway in the Development of Diabetes Mellitus. Biosciences, 14, 129-148. https://doi.org/10.18041/2390-0512/biociencias.2.6026
[50]
Dashti, M.H. and Morshedi, A. (2000) A Comparison Between the Effect of Black tea and Kombucha Tea on Blood Glucose Level in Diabetic Rat. Medical Journal of Islamic World Academy of Sciences, 13, 83-87.
[51]
Cano, R.I. and Ballesteros, P.M.D. (2018) Alternative Therapies in Diabetes. Endocrinology, Diabetes and Nutrition, 65, 189-191. https://doi.org/10.1016/j.endinu.2018.03.001
[52]
Acosta-Recalde, P., Lugo, G., Vera, Z., Morinigo, M., Maidana, G.M. and Samaniego, L. (2018) Use of Medicinal Plants and Herbal Medicine in Patients with Type 2 Diabetes Mellitus. Proceedings of the Health Sciences Research Institute, 16, 6-11. https://doi.org/10.18004/mem.iics/1812-9528/2018.016(02)06-011
[53]
Cuenca-Villalobos, L.P., Uriarte-Sandoval, M.A., Rodríguez-Díaz, J.L. and Parcon, M.B. (2020) Use of Non-Conventional Medicine by Diabetic Patients. Magazine Medical Archive of Camagüey, 24, 65-76.
[54]
Saucedo, T.M.S., Bañuelos, F.N., Cabrera, P.R.M. and Ballesteros, V.M.N. (2006) The Practice of Alternative Medicine, a Reality in the Diabetic Patient in Hermosillo, Son., Mexico. Revista Salud Publica y Nutrición, 7, Article 15.
[55]
Cáceres, A.M.S. and Machain, S.M. (2001) Manual of Use of Medicinal Herbs of Paraguay. Paraguay Traditional Pharmacopoeia Project. Cultural Heritage and Development Strategy. Celestina Pérez de Almada Foundation. Regional Office for Science and Technology for Latin America and the Caribbean UNESCO, Montevideo, 8-72.
[56]
Pinto. C.E. (2017) Influence of Traditional Medicine against the Treatment of Diabetes Mellitus. Rev SALUTA, 1, 74-81.
[57]
Gunther, W.F. (2005) Kombucha: Healthy Drink and Natural Remedy from the Far East, Its Correct Preparation and Use. Monthly Magazine, 102. (In Slang)
[58]
Martínez, L.J., Valenzuela, S.L., Jayabalan, R., Huerta, O.J. and Escalante-Aburto, A. (2018) A Review on Health Benefits of Kombucha Nutritional Compounds and Metabolites. CyTA-Journal of Food, 16, 390-399. https://doi.org/10.1080/19476337.2017.1410499
[59]
González-Téllez, S.V., Olivares-Vázquez, D.A., Espinoza-Raya, J., Ruíz-Durán, R. and Gómez-Pliego, R. (2018) Nutraceutical Fermented Beverages Made from the Kombucha Mushroom and Their Potential Use in the Treatment of Metabolic Syndrome. Research and Development in Food Science and Technology, 3, 338-343.
[60]
Kaewkod, T., Bovonsombut, S. and Tragoolpua, Y. (2019) Efficacy of Kombucha Obtained from Green, Oolong, and Black Teas on Inhibition of Pathogenic Bacteria, Antioxidation, and Toxicity on Colorectal Cancer Cell Line. Microorganisms, 7, Article 700. https://doi.org/10.3390/microorganisms7120700
[61]
Naranjo, Q.J.C. and ávila, C.M.C. (2018) Kombucha. Biology Project. Faculty of Sciences and Education. The Universidad Distrital Francisco José de Caldas, Bogotá.
[62]
Velićanski, A.S., Cvetković, D.D., Markov, S.L., Graves, V.T. and Savatović, S.M. (2007) Antimicrobial and Antioxidant Activity of Lemon Balm Kombucha. Technological Periodic Act, 38, 165-172. https://doi.org/10.2298/APT0738165V
[63]
Stevens, N. (1996) Kombucha: The Extraordinary Tea. Syrian Publisher, Damascus, 5-55.
[64]
Jayabalan, R., Malbaša, R.V., Lončar, E.S., Vitas, J.S. and Sathishkumar, M. (2014) A Review on Kombucha Tea—Microbiology, Composition, Fermentation, Beneficial Effects, Toxicity, and Tea Fungus. Comprehensive Reviews in Food Science and Food Safety, 13, 538-550. https://doi.org/10.1111/1541-4337.12073
[65]
Jayabalan, R., Marimuthu, S. and Swaminathan, K. (2007) Changes in Organic Acid and Polyphenol Content of Tea during Kombucha Tea Fermentation. Food Chemistry, 102, 92-398. https://doi.org/10.1016/j.foodchem.2006.05.032
[66]
Jayabalan, R., Baskaran, S., Marimuthu, S., Swaminathan, K. and Yun, S.E. (2010) Effect of Kombucha Tea on Aflatoxin B1 Induced Acute Hepatotoxicity in Albino Rats-Prophylactic and Curative Studies. Journal of the Korean Society for Applied Biological Chemistry, 53, 407-416. https://doi.org/10.3839/jksabc.2010.063
[67]
Murugesan, G.S., Sathishkumar, M., Jayabalan, R., Binupriya, A.R., Swaminathan, K. and Yun, S.E. (2009) Hepatoprotective and Curative Properties of Kombucha Tea against Carbon Tetrachloride-Induced Toxicity. Journal of Microbiology and Biotechnology, 19, 397-402. https://doi.org/10.4014/jmb.0806.374
[68]
Markov, S., Cvetković, D. and Bukvić, B. (2006) Use of Tea Fungus Isolate as Starter Culture for Obtaining Kombucha. Annals of the Faculty of Engineering Hunedoara, 4, 73-78.
[69]
Herrera, S. and Bruguera, M. (2008) Hepatotoxicity Induced by the Use of Herbs and Weight Loss Drugs. Gastroenterology and Hepatology, 31, 447-453. https://doi.org/10.1157/13125592
[70]
Bhattacharya, S., Oksbjerg, N., Young, J.F. and Jeppesen, P.B. (2014) Caffeic Acid, Naringenin and Quercetin Enhance Glucose-Stimulated Insulin Secretion and Glucose Sensitivity in INS-1E Cells. Diabetes, Obesity and Metabolism, 16, 602-612. https://doi.org/10.1111/dom.12236
[71]
Coskun, O., Kanter, M., Korkmaz, A. and Oter, S. (2005) Quercetin, a Flavonoid Antioxidant, Prevents and Protects Streptozotocin-Induced Oxidative Stress and Beta-Cell Damage in Rat Pancreas. Pharmacological Research, 51, 117-123. https://doi.org/10.1016/j.phrs.2004.06.002
[72]
Matey, P. (2020) Five Scientifically Proven Benefits of kombucha Tea. Feed, Titania Editorial Company. https://www.alimente.elconfidencial.com/nutricion/2020-04-03/beneficios-ciencia-kombucha-coronavirus-covid19_2530711/
[73]
Dufresne, C. and Farnworth, E. (2000) Tea, Kombucha, and Health: A Review. Food Research International, 33, 409-421. https://doi.org/10.1016/S0963-9969(00)00067-3
[74]
Zubaidah, E., Ifadah, R.A, Kalsum, U., Lyrawati, D., Putri, W.D.R., Srianta, I. and Blanc, P.J. (2019) Anti-Diabetes Activity of Kombucha Prepared from Different Snake Fruit Cultivars. Nutrition & Food Science, 49, 333-343. https://doi.org/10.1108/NFS-07-2018-0201
[75]
Nolasco, R.G.N., Nava, K.G.R., Delgado, L.G., Cobos, F.J.B., Albarrán-Rodríguez, E., Peregrina-Sandoval, J. and Rosales-Cortés, M. (2020) Hypoglycemic Effect of Non-Polar Components of Kombucha Extract in a Rat Model of Diabetes. Majorensis, Electronic Journal of Multidisciplinary Sciences, 16, 47-54.
